Guided Therapeutics (GTHP, $0.1) was a top loser over the last three months, falling -2 to $0.1 per share. A.I.dvisor analyzed 454 stocks in the Medical Specialties Industry for the 3-month period ending June 6, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.